| This article has been cited by | | 1 | Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study | | | Sophia Emmons-Bell,Catherine Johnson,Alexandra Boon-Dooley,Paul A. Corris,Peter J. Leary,Stuart Rich,Magdi Yacoub,Gregory A. Roth | | Pulmonary Circulation.2022;12(1) | | [DOI] | | | 2 | Long-term outcomes in pulmonary arterial hypertension by functional class: a meta-analysis of randomized controlled trials and observational registries | | | Nick H. Kim,Micah Fisher,David Poch,Carol Zhao,Mehul Shah,Sonja Bartolome | | Pulmonary Circulation.2020;10(4)1 | | [DOI] | | | 3 | Pulmonary hypertension in Saudi Arabia: First data from the
SAUDIPH
registry with a focus on pulmonary arterial hypertension | | | Abdullah M. Aldalaan,Sarfraz A. Saleemi,Ihab Weheba,Abeer Abdelsayed,Maha M. Aleid,Fatima Alzubi,Hamdeia Zaytoun,Nadeen Alharbi | | Respirology.2021;26(1)92 | | [DOI] | | | 4 | A global view of pulmonary hypertension | | | Marius M Hoeper,Marc Humbert,Rogerio Souza,Majdy Idrees,Steven M Kawut,Karen Sliwa-Hahnle,Zhi-Cheng Jing,J Simon R Gibbs | | The Lancet Respiratory Medicine.2016;4(4)306 | | [DOI] | | | 5 | Chronic thromboembolic pulmonary hypertension in Saudi Arabia: preliminary results from the SAUDIPH registry | | | Abdullah M. Aldalaan,Sarfraz A. Saleemi,Ihab Weheba,Abeer Abdelsayed,Pekka Hämmäinen,Maha M. Aleid,Fatima Alzubi,Hamdeia Zaytoun,Nadeen Alharbi | | ERJ Open Research.2020;6(2)00218-2019 | | [DOI] | | | 6 | Prospective clinical assessment of patients with pulmonary arterial hypertension switched from bosentan to macitentan (POTENT) | | | Abdullah M. Aldalaan,Sarfraz A. Saleemi,Ihab Weheba,Abeer Abdelsayed,Maha M. Aleid,Fatima Alzubi,Hamdeia Zaytoun,Nadeen Alharbi | | Pulmonary Circulation.2022;12(2)00218-2019 | | [DOI] | |
|
|
|
